9 April 2017
On Monday April 10th we will discuss the COMET trial, which is sponsored by the Alliance cooperative group. The principal investigator is Dr. Shelley Hwang, a surgical oncologist at Duke University. This study will evaluate active surveillance for low risk DCIS. The primary objective is to evaluate the rate of ipsilateral (same side) invasive breast cancer in the active surveillance versus the “guideline concordant” group of patients. Secondary objectives include assessments of health related quality of life, anxiety, depression, coping, and intolerance of uncertainty.
More information about the DCIS, the COMET study, and active surveillance can be found at a new website, DCISOptions.org as well as at the following links:
Health News Review podcast with Dr. Laura Esserman – The DCIS Dilemma
Dr. Laura Esserman CBS News When is it OK Not to Treat Breast Cancer
TIME Magazine Breast Cancer Overtreatment – Dr. Shelley Hwang
TIME Magazine 100 Most Influential People – Laura Esserman and Shelley Hwang
Dr. Attai Active Surveillance for DCIS
Dr. Attai DCIS Continued…
Dr. Attai slideshare Are We Overtreating DCIS?
Health News Review Podcast – Active Surveillance for Prostate Cancer